Actively Recruiting

Phase Not Applicable
Age: 6Months - 23Months
All Genders
NCT06382857

Effectiveness of a Microbiome-directed Food to Promote Programmatic and Sustained Nutritional Recovery Among Children With Uncomplicated Acute Malnutrition

Led by Epicentre · Updated on 2024-08-27

7356

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

Sponsors

E

Epicentre

Lead Sponsor

E

Epicentre, Niger

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is an individually randomized controlled trial comparing microbiome-directed foods to standard nutritional therapy among children aged 6 to \< 24 months with uncomplicated acute malnutrition in terms of programmatic recovery by 12 weeks from admission and sustained recovery at 24 weeks from admission.

CONDITIONS

Official Title

Effectiveness of a Microbiome-directed Food to Promote Programmatic and Sustained Nutritional Recovery Among Children With Uncomplicated Acute Malnutrition

Who Can Participate

Age: 6Months - 23Months
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children aged 6 to less than 24 months
  • Severe Acute Malnutrition (SAM) defined by MUAC < 115 mm and/or WLZ < -3 and/or mild (+) or moderate (++) edema
  • Moderate Acute Malnutrition (MAM) defined by 115 mm 64 MUAC < 125 mm and/or -3 64 WHZ < -2
  • Caregiver provides informed consent
Not Eligible

You will not qualify if you...

  • Medical complications requiring inpatient treatment as per national protocol
  • Lack of appetite or not eating as judged by appetite test and investigator
  • Re-admission into the program within 2 months of previous default
  • Referral from inpatient care or supplementary feeding program for SAM cases
  • Referral from SAM treatment for MAM cases
  • Presence of congenital abnormalities or chronic diseases affecting growth or infection risk
  • Known allergy to chickpea, soy flour, banana, or peanut
  • Residence outside study catchment area or living in non-fixed communities (e.g., nomadic)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Epicentre Niger

Maradi, Niger

Actively Recruiting

Loading map...

Research Team

S

Sheila Isanaka, ScD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here